Abstract
Background: Keloid is benign hyperplasia of dermal collagen which may or may not be preceded by injury in susceptible person.
Keloids are refractory to treatment most of the times. Intralesional corticosteroid, topical retinoic acid, topical imiquimod cream,
surgery, cryotherapy, laser, and silicon sheeting are mainly used for treatment. Fractional ablative laser is a new laser treatment
modality that create numerous microscopic thermal injury zone controlled width, depth, and density that are surrounded by
a reservoir of spared epidermal and dermal tissue, allowing of rapid repair of laser-induced thermal injury. Multiple studies
demonstrate that laser pretreatment of the skin can increase the permeability and depth of penetration of topical drug molecules.
Main observations: A boy, 12 years, scar that arise after burn scar 14 months ago. Scar was felt bigger and thickening also
itching. Patient was diagnosed keloid and had been treated with same-session ablative fractional laser and topical triamcinolone
acetonide after therapy. Patient had been treated 5 sessions with 3 weeks of interval. Successful of treatment was measured with
reduction of keloid size and vancouver scar scale (VSS).
Conclusions: Laser assisted drug delivery is an envolving technology with potentially broad clinical application. Ablative
fractional laser treatment create vertical channels that might assist the delivery of drug into skin. Combination same-session
therapy with ablative fractional laser and triamcinolone acetonide offer a good combination caused assisted delivery of drug.
Reference50 articles.
1. 1. Baldwin Hilary (2010) Keloid management. Surgery of the
2. skin, prosedural dermatology. 2nd ed. Mosby Elsevier 669-682.
3. 2. Lovell RC (2016) Disorder of dermal tissue. Rook’s Textbook
4. of Dermatology. 9th ed. New York: Wiley Blackwell 96: 45-49.
5. 3. Burton SC (2012) Escaravage Vaishali. Dermal hypertrophies.